7-Methyl-2,3,4,5-tetrahydro-1-benzoxepin | 41177-64-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: 7-Methyl-2,3,4,5-tetrahydro-1-benzoxepin
• 英文别名: 7-Methyl-homochroman；7-Methyl-2,3,4,5-tetrahydrobenzoxepin-(1)；7-Methyl-2,3,4,5-tetrahydro-benz[b]oxepin；7-Methyl-2,3,4,5-tetrahydro-1-benzoxepine
• CAS: 41177-64-4
• 化学式: C₁₁H₁₄O
• 分子量: 162.232
• InChiKey: DFLOEJKQAASABE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-溴-4-甲基苯酚 在 sodium hydroxide 、 正丁基锂 作用下， 以 水 为溶剂， 反应 8.0h， 生成 7-Methyl-2,3,4,5-tetrahydro-1-benzoxepin
  参考文献：
  名称：

  Oxygen heterocycles by the Parham cyclialkylation

  摘要：

  DOI：

  10.1021/jo00320a032

文献信息

• [EN] HETEROBICYCLE-SUBSTITUTED AZOLYL BENZENE FUNGICIDES<br/>[FR] FONGICIDES D'AZOLYL BENZÈNE SUBSTITUÉ PAR HÉTÉROBICYCLE
  申请人：DU PONT

  公开号：WO2011059619A1

  公开（公告）日：2011-05-19

  Disclosed are compounds of Formula 1, including all stereoisomers, N oxides, and salts thereof, wherein Y is a 5-membered, fully or partially unsaturated heterocyclic ring containing 2-4 carbon atoms and 2-3 nitrogen atoms as ring members, the ring substituted with Z on a ring member atom connected through an adjacent single ring member atom to the ring member atom attaching the heterocyclic ring to the phenyl ring of Formula 1, and optionally further substituted with up to 2 substituents independently selected from R5 on carbon atom ring members and from R6 on nitrogen atom ring members; Z is an 8-, 9-, 10- or 11-membered fused heterobicyclic ring system containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, wherein up to 3 carbon atom ring members are independently selected from C(=O) and C(=S), and the sulfur atom ring members are independently selected from S(=O)u(=NR7)z, the ring system optionally substituted with substituents independently selected from R8 on carbon atom ring members and from R9 on nitrogen atom ring members; and R1, R2, R3, R4, R5, R6, R7, R8, R9, u and z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  公开的是Formula 1的化合物，包括所有立体异构体、N-氧化物和盐，其中Y是一个5元的、完全或部分不饱和的杂环环，含有2-4个碳原子和2-3个氮原子作为环成员，该环在通过相邻的单环成员原子连接到将杂环环连接到Formula 1的苯环上的环成员原子上与Z取代，并且可选地进一步取代最多2个取代基，独立地从碳原子环成员上的R5和氮原子环成员上的R6中选择；Z是一个8、9、10或11元的融合杂双环环系统，其中环成员从碳原子和1到4个异原子中独立选择，这些异原子最多选择2个O、最多2个S和最多4个N原子，其中最多3个碳原子环成员独立选择自C(=O)和C(=S)，硫原子环成员独立选择自S(=O)u(=NR7)z，环系统可选地取代取代基，独立地从碳原子环成员上的R8和氮原子环成员上的R9中选择；以及R1、R2、R3、R4、R5、R6、R7、R8、R9、u和z如披露中所定义。还公开了含有Formula 1的化合物的组合物以及用于控制由真菌病原体引起的植物病害的方法，包括施用本发明的化合物或组合物的有效量。
• POLYCYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS
  申请人：RIGEL PHARMACEUTICALS, INC.

  公开号：US20140323490A1

  公开（公告）日：2014-10-30

  Polycyclic heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.

  本发明涉及多环杂芳基取代的三唑化合物以及含有这些化合物的制药组合物，这些化合物被揭示为在抑制受体蛋白酪氨酸激酶Axl的活性方面有用。还揭示了使用这些化合物治疗与Axl活性相关的疾病或病状的方法。
• HETEROBICYCLE-SUBSTITUTED AZOLYL BENZENE FUNGICIDES
  申请人：Andreassi II John Lawrence

  公开号：US20120202815A1

  公开（公告）日：2012-08-09

  Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein Y is a 5-membered, fully or partially unsaturated heterocyclic ring containing 2-4 carbon atoms and 2-3 nitrogen atoms as ring members, the ring substituted with Z on a ring member atom connected through an adjacent single ring member atom to the ring member atom attaching the heterocyclic ring to the phenyl ring of Formula 1, and optionally further substituted with up to 2 substituents independently selected from R 5 on carbon atom ring members and from R 6 on nitrogen atom ring members; Z is an 8-, 9-, 10- or 11-membered fused heterobicyclic ring system containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2O, up to 2S and up to 4 N atoms, wherein up to 3 carbon atom ring members are independently selected from C(═O) and C(═S), and the sulfur atom ring members are independently selected from S(═O) u (═NR 7 ) z , the ring system optionally substituted with substituents independently selected from R 8 on carbon atom ring members and from R 9 on nitrogen atom ring members; and R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , u and z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  本文披露了一种公式1的化合物，包括所有立体异构体、N-氧化物和其盐。其中Y是一个五元杂环环，完全或部分不饱和，包含2-4个碳原子和2-3个氮原子作为环成员，环上通过相邻的单个环成员原子连接到连接杂环环和公式1苯环的环成员原子上的Z进行取代。环还可以进一步取代最多2个取代基，独立地从碳原子环成员和氮原子环成员的R5和R6中选择。Z是一个8、9、10或11个成员的融合杂双环系统，其中环成员选择自碳原子和1至4个杂原子，独立地从最多2个O、最多2个S和最多4个N原子中选择，其中最多3个碳原子环成员独立地选择自C（═O）和C（═S），硫原子环成员独立地选择自S（═O）u（═NR7）z，环系统还可以进一步取代独立地从碳原子环成员的R8和氮原子环成员的R9中选择的取代基。R1、R2、R3、R4、R5、R6、R7、R8、R9、u和z如本文所定义。本文还披露了含有公式1化合物的组合物，并且披露了一种通过施用本发明的化合物或组合物的有效量来控制由真菌病原体引起的植物病害的方法。
• KINASE MODULATORS
  申请人：Rhizen Pharmaceuticals S.A.

  公开号：EP3050876A2

  公开（公告）日：2016-08-03

  The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

  本发明提供了 PI3K 蛋白激酶调节剂、制备方法、含有这些调节剂的药物组合物以及用它们治疗、预防和/或改善激酶介导的疾病或紊乱的方法。
• CAGNIANT, Comptes rendus hebdomadaires des seances de l'Academie des sciences, 1949, vol. 229, # 18, p. 889 - 891
  作者：CAGNIANT

  DOI：——

  日期：——